BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«SARS Severe Acute Respiratory

Below is an extended SARS Severe Acute Respiratory research listing. Click here to return to the SARS Severe Acute Respiratory main in depth entry.

Recent Publications on SARS Severe Acute Respiratory:

Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.
Although the 2003 severe acute respiratory syndrome (SARS) outbreak was...
Direct Link
30th August, 2008
University of British Columbia Centre for Disease Control, Vancouver, BC
The M, E and N structural proteins of the SARS coronavirus are required for efficient assembly, trafficking and release of virus-like particles.
Production of virus-like particles (VLPs) constitutes a relevant and safe...
Direct Link
30th August, 2008
From the HKU-Pasteur Research Centre, 8 Sassoon Road, Hong Kong SAR,
Health impact of hospital restrictions on seriously ill hospitalized patients: lessons from the Toronto SARS outbreak.
BACKGROUND: Restrictions on non-urgent hospital care imposed to control...
Direct Link
30th August, 2008
Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Development of Human Single-Chain Antibodies against SARS-Associated Coronavirus.
The outbreak of severe acute respiratory syndrome (SARS), caused by a...
Direct Link
30th August, 2008
CK Life Sciences International Inc., Hong Kong, SAR, China.
A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress and JNK-dependent apoptosis.
Severe acute respiratory syndrome (SARS) coronavirus (CoV) spread from...
Direct Link
19th August, 2008
Department of Biology, The Hong Kong University of Science and Technology,
Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CL(pro) inhibitors.
Since the emergence of the severe acute respiratory syndrome (SARS) to...
Direct Link
19th August, 2008
Department of Pharmacognosy, Faculty of Pharmacy, Mahidol University,
Dissection and identification of regions required to form pseudoparticles by the interaction between the nucleocapsid (N) and membrane (M) proteins of SARS coronavirus.
When expressed in mammalian cells, the nucleocapsid (N) and membrane (M)...
Direct Link
16th August, 2008
Department of Infectious Diseases, Research Institute, International
Disaster and emergency management: Canadian nurses' perceptions of preparedness on hospital front lines. 16th August, 2008
Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.
[Clinical application of radionuclide bone scintigraphy in diagnosis of avascular osteonecrosis in patients with severe acute respiratory syndrome in convalescence] 9th August, 2008
Department of Nuclear Medicine, PUMC Hospital, CAMS and PUMC, Beijing
Bench-to-bedside review: Rare and common viral infections in the intensive care unit - linking pathophysiology to clinical presentation.
ABSTRACT: Viral infections are common causes of respiratory tract disease...
Direct Link
2nd August, 2008
Division of Pulmonary and Critical Care Medicine, University of
STRUCTURAL FLEXIBILITY OF THE PENTAMERIC SARS CORONAVIRUS ENVELOPE PROTEIN ION CHANNEL.
Coronaviruses contain a small envelope (E) membrane protein with...
Direct Link
29th July, 2008
Nanyang Technological University.
The Transmembrane Domain of the SARS-CoV ORF7b Protein is Necessary and Sufficient for Its Retention in the Golgi Complex.
The Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) ORF7b (also...
Direct Link
18th July, 2008
Departments of Molecular Microbiology, Medicine and Pathology &
Impact of severe acute respiratory syndrome on patient access to palliative radiation therapy.
This study evaluated the impact of the severe acute respiratory syndrome...
Direct Link
17th July, 2008
Department of Radiation Oncology, University of Toronto.
Frameshifting RNA pseudoknots: Structure and mechanism.
Programmed ribosomal frameshifting (PRF) is one of the multiple...
Direct Link
16th July, 2008
Department of Chemistry, Indiana University, 212 S. Hawthorne Drive,
A rapid point of care immunoswab assay for SARS-CoV detection.
The emergence of severe acute respiratory syndrome (SARS) resulted in...
Direct Link
16th July, 2008
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional